JULY 2014 WEBINAR NOW AVAILABLE FOR DOWNLOAD OR STREAMING
YouTube video is best viewed by pressing play and clicking on settings (gear) and changing to 720p HD. Duration of presentation is 50 minutes.
Managing High-Cost Physician-Administered Drugs: A Payer Perspective
Learn the latest about how payers plan to manage ever-increasing oncology drug costs.
Specialty drug spend is expected to more than quadruple by 2020, reaching approximately $400 billion a year. Roughly half of that spend is for physician-administered drugs, driven largely by oncology. What options are payers considering to control access and costs? What are the implications for manufacturers?
Presentation features findings from in-depth, hour-long interviews with 14 Medical Directors from BioMedical Insights’ managed care organization (MCO) panel.
The Webinar was presented in July 2014.
Elizabeth Brooks is a Founding Partner of BioMedical Insights. She has analyzed markets for dozens of medical product companies and has provided due diligence support to numerous investors. She is expert at reimbursement issues, offering education, analysis, strategic and tactical support to pharmaceutical and biotechnology concerns, as well as medical device companies. In addition, Ms. Brooks has developed a model for helping companies evaluate the need for pharmacoeconomic studies and has trained hundreds of staff on the appropriate use of outcomes research tools. Ms. Brooks holds a Masters of Business Administration and an Honors Bachelor of Arts degree in English, both from the University of Chicago.
Chris Nicita is also a Founding Partner of BioMedical Insights. He specializes in technology assessments, new product planning, portfolio review, and marketing strategy. His business experience, combined with his background in molecular biology research, enables him to understand the scientific and clinical sides of new medical technologies, as well as their commercial potential. Mr. Nicita has worked with a range of companies, from industry leaders to start-ups, to make sound portfolio investment decisions and to optimize clinical development strategy. He frequently consults to companies on prospective in-licensing and merger and acquisition candidates, and has provided due diligence services to a variety of healthcare investors. Mr. Nicita holds a Masters of Business Administration and an Honors Bachelor of Science in Molecular Biology, both from the University of Michigan.
Quotes From Attendees:
“Very good presentation. Information was presented clearly and would be a great overview for anyone of the space. I learned some different models for shared savings/risk. It was also a great level set of what is happening, new, etc… Thank you for the opportunity to learn something about the changes happening.” – Associate Director, US Market Access
“I thought the webinar was very well done. There were good ‘nuances’ discussed that were thought-provoking.” – VP Marketing
“…Thank you for the extremely brilliant presentation you gave yesterday on ‘Managing High-Cost Physician-Administered Drugs – A Payer Perspective.’ It was most outstanding.” – Global Regulatory Affairs
“Really well done. Great insights, examples and explanations.” – Director, Global Pricing and Reimbursement
“It really went in depth – I think my team really appreciated that.” – Senior VP, Bus Dev